SCHD Is Brilliant. Here's Why I Think This Dividend ETF Is Even Better.

First Trust Rising Dividend Achievers ETF (RDVY) delivered a 15.8% average annual total return over the past decade, exceeding Schwab U.S. Dividend Equity ETF's (SCHD) 13.2%. RDVY emphasizes faster-growing Nasdaq-listed dividend raisers, with 30% financials, 26% technology, and a 0.8% trailing yield, while SCHD prioritizes higher current income with a 3.0% yield and exposure to healthcare, consumer staples, and energy. The article favors RDVY for long-term wealth accumulation and SCHD for investors seeking dividend income.

Analysis

The relevant exposure is not “dividend growth” but factor composition: RDVY is effectively a concentrated financials/semis/industrials allocation, while SCHD carries meaningful staples and healthcare duration. The historical return gap therefore likely reflects a favorable growth, bank and AI-capex regime rather than a durable security-selection advantage. Investors rotating from SCHD into RDVY after headline performance are implicitly adding cyclicality, higher earnings-revision sensitivity and Nasdaq concentration while sacrificing income carry.

Near term, this is unlikely to move META or NVDA; both are too large for marginal ETF-flow effects to matter. The more actionable implication is relative performance under changing rates: falling real yields and continued upward EPS revisions favor RDVY’s technology exposure, while a growth scare, credit deterioration, or renewed rate volatility should favor SCHD’s KO, PG and PEP-heavy defensive cash-flow profile. PEP is the weak link within the defensive basket if volume and pricing normalization continue to pressure organic growth, whereas KO’s asset-light model is better positioned to preserve margins.

Consensus may be extrapolating a backward-looking total-return comparison without adjusting for starting valuation and sector weights. A softer labor or consumer-data sequence over the next 1-3 months would make SCHD’s lower-beta earnings stream comparatively attractive; over 6-18 months, the decisive variable is whether AI-led capex converts into broad earnings growth rather than remaining concentrated in NVDA and a handful of platform beneficiaries. The thesis for RDVY is falsified by broad downward revisions in financials/industrials or a material slowdown in semiconductor demand; the SCHD defense case is falsified by reaccelerating growth and stable-to-lower real rates.

Key Decisions for Investors

• No standalone trade on the article; use it as a factor-allocation signal rather than a catalyst for META or NVDA, where ETF-related flows are immaterial.
• For a 1-3 month macro hedge, consider a tactical long SCHD / short RDVY pair if payrolls, ISM new orders, or bank credit trends weaken. Target a 5-8% relative move; exit if real yields decline materially while broad EPS revisions remain positive, which would support RDVY’s growth tilt.
• Within defensives, favor KO over PEP for 6-12 months: KO has more resilient margin architecture and less exposure to the volume/pricing reset. Reassess if KO’s organic-growth guidance weakens or PEP demonstrates sustained volume recovery.
• Maintain NVDA and META exposure only where supported by independent earnings estimates; do not treat their token dividend yields as a defensive characteristic. Trim relative growth exposure if semiconductor order visibility or hyperscaler capex guidance turns down.